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OBJECTIVES This study was designed to assess the relation of electrocardiographic (ECG) strain to
increased left ventricular (LV) mass, independent of its relation to coronary heart disease
(CHD).
BACKGROUND The classic ECG strain pattern, ST depression and T-wave inversion, is a marker for left
ventricular hypertrophy (LVH) and adverse prognosis. However, the independence of the
relation of strain to increased LV mass from its relation to CHD has not been extensively
examined.
METHODS Electrocardiograms and echocardiograms were examined at study baseline in 886 hyperten-
sive patients with ECG LVH by Cornell voltage-duration product and/or Sokolow-Lyon
voltage enrolled in the Losartan Intervention For End point (LIFE) echocardiographic
substudy. Strain was defined as a downsloping convex ST segment with inverted asymmetrical
T-wave opposite to the QRS axis in leads V5 and/or V6.
RESULTS Strain occurred in 15% of patients, more commonly in patients with than without evident
CHD (29%, 51/175 vs. 11%, 81/711, p , 0.001). When differences in gender, race, diabetes,
systolic pressure, serum creatinine and high density lipoprotein cholesterol were controlled,
strain on baseline ECG was associated with greater indexed LV mass in patients with (152 6
33 vs. 131 6 32 g/m2, p , 0.001) or without CHD (131 6 24 vs. 119 6 22 g/m2, p , 0.001).
In logistic regression analyses, strain was associated with an increased risk of anatomic LVH
in patients with CHD (relative risk 5.14, 95% confidence interval [CI] 1.16 to 22.85, p 5
0.0315), without evident CHD (relative risk 2.91, 95% CI 1.50 to 5.65, p 5 0.0016), and in
the overall population when CHD was taken into account (relative risk 2.98, 95% CI 1.65 to
5.38, p 5 0.0003).
CONCLUSIONS When clinical evidence of CHD is accounted for, ECG strain is likely to indicate the
presence of anatomic LVH. Greater LV mass and higher prevalence of LVH in patients with
strain offer insights into the known association of the strain pattern with adverse outcomes.
(J Am Coll Cardiol 2001;38:514–20) © 2001 by the American College of Cardiology
The classic strain pattern of ST depression and T-wave
inversion on the rest electrocardiogram (ECG) is a well-
recognized marker of the presence of anatomic left ventric-
ular hypertrophy (LVH) (1–6). This abnormality of repo-
larization has been associated with an adverse prognosis in a
variety of clinical populations (7–11) and implicated as the
strongest marker of untoward outcomes when ECG LVH
criteria have been utilized for risk stratification (8–10).
Moreover, the strain pattern could also reflect underlying
coronary heart disease (CHD), a relationship that could in
part explain the clinical consequences of this ECG finding
beyond those directly attributable to high left ventricular
(LV) mass (3,4,8,10). However, the independent relation-
ship of ECG strain to LV mass, as opposed to its potential
relation to CHD, has not been extensively examined. Thus,
the present study examined the relation of the strain pattern
on the rest ECG to LV mass and the presence of anatomic
LVH, taking into account potential effects of coexistent
CHD and controlling for other clinical and demographic
variables that could potentially affect these relationships.
METHODS
Subjects. The Losartan Intervention For End point
(LIFE) study (12,13) enrolled hypertensive patients with
ECG LVH by Cornell voltage-duration product (14,15)
and/or Sokolow-Lyon voltage (1) on a screening ECG in a
prospective double-blind study to determine whether appre-
ciable reduction in mortality and morbid events is associated
with the use of losartan as opposed to atenolol (12). Eligible
patients for LIFE were hypertensive men and women aged
55 to 80 years with a seated blood pressure of 160 to 200/95
to 115 mm Hg after one and two weeks on placebo. Study
inclusion and exclusion criteria have been previously pub-
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lished (12,13). A previously described (16) representative
sample of the whole LIFE study, totaling 964 patients,
underwent baseline echocardiograms; 21 patients had un-
measurable echocardiographic LV mass and 57 had incom-
plete baseline ECG measurements. There were 361 eligible
women and 525 eligible men whose mean age was 66 6 7
years.
Electrocardiography. All ECGs were interpreted at the
Core Laboratory at Sahlgrenska University Hospital/O¨stra
in Go¨teborg, Sweden, by investigators blinded to the
clinical information (12,13). The product of QRS dura-
tion 3 Cornell voltage (RaVL 1 SV3, with 8 mm added in
women [14,15]) was used with a threshold value of
2,440 mm z ms to identify LVH. After design of LIFE,
studies were published suggesting a smaller gender adjust-
ment (6,17), and feedback from LIFE investigators showed
that otherwise eligible patients had ECG LVH by highly
specific but insensitive Sokolow-Lyon voltage criteria (1),
but not by Cornell product. Accordingly, changes were
made in ECG entry criteria: the gender adjustment of
Cornell voltage was reduced from 8 to 6 mm and Sokolow-
Lyon voltage (SV1 1 RV5/6) .38 mm was accepted for
ECG eligibility (13). Additional ECG measurements were
performed at Helsinki University Central Hospital. Repo-
larization abnormalities in leads V5 and/or V6 indicated
typical strain (11) when there was a downsloping convex ST
segment with an inverted asymmetrical T-wave opposite to
the QRS axis.
Echocardiography. Studies were performed using funda-
mental imaging with commercially available phased-array
echocardiographs as previously described (16,18). Left ven-
tricular internal dimension and wall thicknesses were mea-
sured at end-diastole by American Society of Echocardiog-
raphy (ASE) recommendations (19) on up to three cardiac
cycles. When M-mode recordings could not be optimally
oriented, correctly oriented linear dimension measurements
were made using two-dimensional imaging by leading-edge
ASE convention (20). Methods for measurement and evi-
dence of interchangeability of two-dimensional and
M-mode LV dimensions have been described in detail (18).
Relative wall thickness was calculated as end-diastolic pos-
terior wall thickness/LV radius; LV mass was calculated
(21) and was indexed for body surface area and alternatively
for height2.7 (22). Under criteria known to predict an
adverse prognosis (23–25), LVH was considered present if
LV mass index was .104 g/m2 in women or .116 g/m2
in men. Hypertrophy was considered concentric if LV
relative wall thickness was .0.430 and eccentric if relative
wall thickness was normal (16); patients with normal LV
mass were considered to have normal LV geometry if
relative wall thickness was #0.43 or to have concentric
remodeling if relative wall thickness was increased. Alter-
native analyses used LV mass/height2.7 partition values of
46.7 and 49.2 g/m2.7 in women and men, respectively.
Myocardial contractile performance was assessed by ex-
amining LV systolic shortening in relation to circumferen-
tial end-systolic stress (ESS) (26). The relation of LV
midwall shortening to midwall circumferential ESS at the
LV minor axis was calculated as previously described (27),
and was expressed as a percent of the value predicted from
circumferential ESS by an equation derived in apparently
normal adults (28). This variable, stress-corrected midwall
shortening was considered low if ,89.2%, the 5th percentile
in a separate reference population of 280 normal adults (28).
To estimate myocardial oxygen demand, the ESS-LV
mass-heart rate product was calculated as previously de-
scribed (29). Fractional and midwall shortening could be
determined in 100% of patients, whereas circumferential
ESS, stress-corrected midwall shortening and ESS-LV
mass-heart rate product could be determined in 97% (857/
886) of patients in this study.
Statistics. Patients were classified as having CHD if they
had self-reported angina or myocardial infarction, diagnos-
tic Q-waves by Minnesota code on the ECG or segmental
wall motion abnormalities on the two-dimensional echocar-
diogram. Differences in prevalence were compared using x2
analyses and mean values of continuous variables by un-
paired t test. Echocardiographic variables were further
compared using analysis of covariance to adjust for differ-
ences in age, gender, race, systolic pressure, cholesterol and
high density lipoprotein (HDL) cholesterol, creatinine and
prevalent diabetes between groups. Independent relations of
echocardiographic LVH, abnormal LV geometry and ab-
normal stress-corrected midwall shortening to ECG strain
were determined using stepwise logistic regression analyses
and the same covariates. A two-tailed p , 0.05 was required
for statistical significance.
RESULTS
Patient characteristics. Strain was present in 132 patients
(15%) and was more common in patients with CHD than in
those without (29%, 51/175 vs. 11%, 81/711, p , 0.001).
Clinical and demographic characteristics of patients with or
without strain on the ECG, stratified by CHD status, are
shown in Table 1. Among patients without CHD, those
with typical strain were more likely to be men and African-
American with higher systolic pressures, lower HDL cho-
lesterol and higher serum creatinine levels than patients
without strain. Among patients with evident CHD, those
with strain similarly were more likely to be African-
Abbreviations and Acronyms
ASE 5 American Society of Echocardiography
CHD 5 coronary heart disease
ECG 5 electrocardiogram, electrocardiographic
ESS 5 end-systolic stress
HDL 5 high density lipoprotein
LIFE 5 Losartan Intervention For End point study
LV 5 left ventricular
LVH 5 left ventricular hypertrophy
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American, have higher serum creatinine, a slightly lower
HDL cholesterol, and a greater prevalence of diabetes, but
were similar to patients without strain with regard to
gender, systolic pressure and serum sodium and potassium
levels.
Echocardiographic findings in relation to ECG strain.
Relations of LV structure and function to the presence or
absence of ECG strain are examined in Table 2. In patients
with or without CHD, strain on the ECG was associated
with greater LV wall thicknesses, LV mass and LV mass
indexed for either body surface area or for height2.7. Among
patients without CHD, LV internal dimensions were also
greater in patients with strain. In both patient groups,
because strain was associated with a greater increase in LV
wall thickness than cavity dimension, strain was also asso-
ciated with increased relative wall thickness. Strain was
associated with similar LV performance at the endocar-
dium, as measured by fractional shortening, and with similar
levels of circumferential ESS, but patients with strain had
lower LV midwall performance than predicted for the level
of ESS, as reflected by lower stress-corrected midwall
shortening. Electrocardiographic strain was associated with
increased wall mass-stress-heart rate product only among
patients without CHD.
Prevalences of echocardiographic LVH, abnormal LV
geometry and LV midwall function in patients with or
without ECG strain are shown in Table 3. In this popula-
tion selected on the basis of ECG LVH by Cornell product
and/or Sokolow-Lyon voltage, strain was associated with a
higher prevalence of LVH defined by LV mass/body surface
area in patients with and without CHD. Alternative anal-
yses using gender-specific LV mass/height2.7 partitions
confirmed higher prevalences of LVH in patients with
ECG strain, both in those with CHD (92% vs. 84%, p 5
Table 1. Demographic and Clinical Characteristics in Relation to Electrocardiographic Strain in Hypertensive Patients With and
Without Evident CHD
Variable
No CHD CHD
Strain2
(n 5 630)
Strain1
(n 5 81) p Value
Strain2
(n 5 124)
Strain1
(n 5 51) p Value
Age (yrs) 65.8 6 7.1 66.6 6 5.8 0.239 67.2 6 7.0 68.8 6 6.7 0.178
Gender (% male) 55.6 71.6 0.009 65.3 70.6 0.597
Race (% African-American) 11.7 30.9 , 0.001 8.9 27.5 0.003
Diabetes (%) 8.4 8.6 1.000 13.7 31.4 0.010
Systolic blood pressure (mm Hg) 172.4 6 14.2 178.1 6 12.9 0.001 174.4 6 15.6 175.3 6 13.7 0.721
Diastolic blood pressure (mm Hg) 98.7 6 8.3 100.4 6 8.8 0.093 96.8 6 9.7 94.9 6 11.7 0.265
Body mass index (kg/m2) 27.3 6 4.3 26.9 6 4.5 0.386 27.6 6 5.8 27.4 6 6.0 0.820
Total cholesterol (mM) 6.06 6 1.12 5.88 6 1.14 0.195 5.65 6 1.05 5.60 6 1.12 0.781
HDL cholesterol (mM) 1.56 6 0.47 1.44 6 0.46 0.042 1.45 6 0.37 1.33 6 0.37 0.062
Creatinine (mM) 88.0 6 22.2 97.2 6 24.3 0.002 93.6 6 20.3 103.3 6 22.8 0.007
Serum sodium (mM/l) 140.2 6 2.3 140.4 6 2.4 0.551 139.9 6 2.8 139.8 6 2.7 0.774
Serum potassium (mM/l) 4.16 6 0.42 4.06 6 0.37 0.058 4.15 6 0.39 4.19 6 0.35 0.511
CHD 5 coronary heart disease; HDL 5 high density lipoprotein.
Table 2. Echocardiographic Findings in Relation to Electrocardiographic Strain in Hypertensive Patients With and Without Evident
CHD
Variables
No CHD CHD
Strain2
(n 5 630)
Strain1
(n 5 81) p Value
Strain2
(n 5 124)
Strain1
(n 5 51) p Value
LVIDD (cm) 5.20 6 0.53 5.34 6 0.59 0.035 5.56 6 0.65 5.62 6 0.64 0.533
IVSD (cm) 1.14 6 0.14 1.24 6 0.19 , 0.001 1.14 6 0.14 1.25 6 0.19 , 0.001
PWTD (cm) 1.06 6 0.11 1.14 6 0.15 , 0.001 1.06 6 0.10 1.15 6 0.17 , 0.001
Relative wall thickness 0.41 6 0.06 0.43 6 0.09 0.007 0.39 6 0.06 0.41 6 0.08 0.017
LV mass (g) 223 6 48 259 6 68 , 0.001 249 6 59 286 6 71 , 0.001
LV mass index* (g/m2) 118 6 22 134 6 29 , 0.001 131 6 27 151 6 34 , 0.001
LV mass index† (g/m2.7) 54 6 13 59 6 14 0.002 60 6 18 69 6 19 0.005
Fractional shortening (%) 34 6 5 34 6 6 0.487 30 6 7 30 6 8 0.781
Midwall shortening (%) 15.8 6 2.0 15.0 6 1.9 0.001 14.8 6 2.1 13.9 6 2.5 0.029
Circumferential end-systolic stress
(kdynes/cm2)
176 6 41 183 6 54 0.255 211 6 59 207 6 70 0.750
Stress-corrected midwall shortening
(% predicted)
98 6 13 95 6 12 0.046 96 6 12 90 6 16 0.006
Stress-mass-HR product
(kdyneszg/minzcm2 3 106)
2.72 6 1.13 3.21 6 1.48 0.001 3.77 6 1.95 4.08 6 1.76 0.340
*Indexed to body surface area; †indexed to height2.7.
CHD 5 coronary heart disease; HR 5 heart rate; IVSD 5 intraventricular septal thickness in diastole; LV 5 left ventricular; LVIDD 5 LV internal dimension in diastole;
PWTD 5 posterior wall thickness in diastole.
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0.226) and without CHD (82% vs. 70%, p 5 0.039).
Independent of the presence or absence of evident CHD,
patients with strain were less likely than those without strain
to have normal LV geometry or concentric remodeling and
had a similar prevalence of eccentric LVH, but were much
more likely to have concentric LVH than patients without
strain on the rest ECG. Depressed LV contractility, as
estimated by stress-corrected midwall shortening ,89.2%,
was more common in CHD patients with strain, but did not
differ in prevalence in patients without CHD according to
the presence or absence of strain.
Because patients with and without strain differed with
respect to demographic and clinical variables that could
affect LV structure and function (Table 1), independent
relations of echocardiographic findings to the presence of
strain were examined in patients with and without CHD by
analysis of covariance (Table 4). After adjusting for baseline
differences, strain remained strongly associated with in-
creased LV wall thicknesses, relative wall thickness, LV
mass and LV mass indices in patients with and without
CHD. Left ventricular internal dimensions, fractional
shortening and ESS were similar in patients with or without
strain, but midwall shortening remained moderately de-
pressed in those with strain. Similarly, after taking into
account differences in systolic pressure and normalizing for
differences in LV dimension between groups, ESS was
similar in patients with and without strain, but stress-
corrected midwall shortening remained lower in patients
with strain, attaining statistical significance in patients with
CHD. Wall stress-mass-heart rate product was elevated in
patients without evident CHD after adjusting for baseline
differences.
In parallel fashion, relations of echocardiographic LVH,
abnormal LV geometry and depressed LV contractility to
strain were further examined using separate logistic regres-
sion analyses in patients with and without CHD (Table 5).
After adjusting for baseline differences, ECG strain was
associated with a nearly threefold greater risk of LVH in
patients without CHD and a greater than fivefold increased
risk of echocardiographic LVH in patients with CHD. In
nominal regression analyses where the risk of abnormal LV
geometry compared with normal geometry was determined
for the presence of strain, ECG strain was most strongly
related to increased risk of concentric LVH, was strongly
Table 3. Prevalence of Echocardiographic LVH, Abnormal LV Geometry and Abnormal LV Midwall Function in Relation to
Electrocardiographic Strain in Hypertensive Patients With and Without Evident CHD
Variables
No CHD CHD
Strain2
(n 5 630)
Strain1
(n 5 81) p Value
Strain2
(n 5 124)
Strain1
(n 5 51) p Value
LVH (%)* 64.0 81.5 0.003 83.1 96.1 0.025
LV geometry (%) 0.003 0.011
Normal (n 5 155) 22.8 13.6 11.3 2.0
Concentric remodeling (n 5 88) 13.2 4.9 5.6 2.0
Eccentric hypertrophy (n 5 307) 43.0 45.7 62.9 54.9
Concentric hypertrophy (n 5 161) 21.0 35.8 20.2 41.2
Stress-corrected midwall shortening ,89.2% (%) 24.0 27.8 0.471 26.1 49.0 0.006
*Left ventricular mass .104 g/m2 in women and .116 g/m2 in men.
CHD 5 coronary heart disease; LV 5 left ventricular; LVH 5 left ventricular hypertrophy.
Table 4. Echocardiographic Findings in Relation to Electrocardiographic Strain in Hypertensive Patients With and Without Evident
CHD Adjusted for Differences in Clinical and Demographic Variables*
Variables
No CHD CHD
Strain2
(n 5 630)
Strain1
(n 5 81) p Value
Strain2
(n 5 124)
Strain1
(n 5 51) p Value
LVIDD (cm) 5.21 6 0.53 5.26 6 0.57 0.401 5.56 6 0.67 5.61 6 0.70 0.672
IVSD (cm) 1.14 6 0.15 1.22 6 0.17 , 0.001 1.15 6 0.17 1.25 6 0.17 , 0.001
PWTD (cm) 1.06 6 0.13 1.13 6 0.13 , 0.001 1.06 6 0.13 1.16 6 0.13 , 0.001
Relative wall thickness 0.41 6 0.08 0.43 6 0.07 0.014 0.39 6 0.07 0.42 6 0.07 0.009
LV mass (g) 224 6 46 249 6 50 , 0.001 250 6 65 286 6 68 0.002
LV mass index* (g/m2) 119 6 22 131 6 24 , 0.001 131 6 32 152 6 33 , 0.001
LV mass index (g/m2.7) 55 6 13 58 6 14 0.040 59 6 16 70 6 17 , 0.001
Fractional shortening (%) 34 6 5 35 6 5 0.736 30 6 8 30 6 7 0.945
Midwall shortening (%) 15.8 6 2.5 15.3 6 1.8 0.060 14.6 6 2.2 13.9 6 2.2 0.083
Circumferential end-systolic stress
(kdynes/cm2)
176 6 43 176 6 47 0.933 212 6 66 204 6 69 0.476
Stress-corrected midwall shortening
(% predicted)
98 6 13 95 6 14 0.081 95 6 13 90 6 14 0.016
Stress-mass-HR product
(kdyneszg/minzcm2 3 106)
2.73 6 1.11 3.03 6 1.13 0.040 3.84 6 1.91 3.99 6 1.95 0.675
*Adjusted for age, gender, race, prevalent diabetes, systolic blood pressure, high density lipoprotein cholesterol and creatinine. Abbreviations as in Table 2.
517JACC Vol. 38, No. 2, 2001 Okin et al.
August 2001:514–20 Strain and Hypertrophy
associated with presence of eccentric LVH and was not
related to concentric remodeling in patients with or without
evident CHD. Strain remained associated with decreased
LV contractility, as determined by stress-corrected midwall
shortening ,89.2%, in patients with CHD but not in
patients without evident CHD. Of note, logistic regression
analyses performed in the entire study population using an
indicator variable for CHD confirmed these relations, dem-
onstrating that ECG strain was strongly associated with
echocardiographic LVH, especially of concentric pattern,
and was modestly related to depressed stress-corrected
midwall shortening.
DISCUSSION
This study demonstrates that typical strain on the ECG in
hypertensive patients identifies patients with greater LV
mass, a higher prevalence of echocardiographic LVH that is
more likely to be concentric, and lower myocardial contrac-
tility and higher estimated myocardial oxygen demand,
independent of the presence of clinically evident CHD and
other demographic and clinical differences between patients
with and without strain. These findings offer insights into
the known association of the strain pattern with adverse
outcomes in hypertensive patients and suggest that further
evaluation of the diagnostic and prognostic values of quan-
titative measures of strain, as reflected by the magnitude of
ST depression and/or T-wave amplitude, is indicated.
Relationship of strain to LVH. Previous studies have
documented a clear relation between strain and anatomic
LVH (1–3,5,6) and an increased prevalence of strain with
more severe hypertrophy (3). However, most studies did not
account for potential effects of concomitant CHD, which is
highly covariate with LVH (4,24,25) and could contribute
to the genesis of ST/T-wave changes (3,8,10). Schillaci et
al. (6) demonstrated low sensitivity (16%) and high speci-
ficity (98%) of strain for LVH in 923 white hypertensive
patients without clinically evident CHD, but did not exam-
ine differences in LV structure and mass in relation to strain.
In a subset of 40 patients with severe isolated aortic
regurgitation without significant obstructive CHD at an-
giography, Roman et al. (11) demonstrated that strain was
associated with greater LV mass. However, neither study
adjusted for other variables that could affect the relation
between strain and increased LV mass. The current study
significantly extends these observations to a large cohort of
patients with hypertension, demonstrating that strain is
associated with greater LV mass, indexed LV mass and
higher prevalences of echocardiographic LVH in patients
with and without CHD, even after taking into account
baseline differences that could contribute to differences in
the prevalence of ECG strain.
Development of typical ST segment and T-wave changes
of the strain pattern in response to hypertrophy is predicted
by a distributed dipole model of the ECG response to
hypertrophy (30), which demonstrates that T-wave ampli-
tudes are proportional to the square of the cell radius and
that the flattening or inversion of the T-wave observed with
LVH can be attributed to the contiguity effect of adjacent
layers having different transmembrane action potential du-
rations. These findings suggest that greater degrees of ST
depression and T-wave inversion will be associated with
larger increases in LV mass, consistent with the linear
relations of these variables to LV mass (31).
Relationship of strain to LV geometry. The relationship
of strain to LV geometry has been less well studied. In 107
patients not on digitalis (3), strain was more strongly
associated with an LV internal dimension .55 mm (50% vs.
13%, p , 0.01) than with posterior wall thickness .12 mm
(31% vs. 14%, p 5 0.06), suggesting a stronger relationship
between strain and eccentric as opposed to concentric
hypertrophy. Among patients with pure aortic regurgitation
(11), typical strain was associated with both increased LV
Table 5. Multivariate Logistic Regression Analyses to Assess the Predictive Value of Electrocardiographic Strain for the Presence of
LVH, Abnormal LV Geometry and Abnormal LV Midwall Function in Patients With and Without Evident CHD*
Variable x2 p Value Beta Coefficient Relative Risk 95% CI
No Evident CHD
LVH 9.91 0.0016 1.067 2.91 1.50–5.65
LV geometry† 14.17 0.003
Concentric remodeled 0.985 0.013 1.01 0.29–3.59
Eccentric hypertrophy 0.030 0.919 2.51 1.09–5.76
Concentric hypertrophy 0.002 1.358 3.89 1.64–9.25
Stress-corrected midwall shortening ,89.2% 0.23 0.630 0.137 1.15 0.66–2.00
CHD
LVH 4.63 0.0315 1.637 5.14 1.16–22.85
LV geometry† 10.13 0.016
Concentric remodeled 0.554 0.905 2.47 0.12–49.52
Eccentric hypertrophy 0.124 1.687 5.41 0.63–46.33
Concentric hypertrophy 0.023 2.557 12.89 1.43–116.65
Stress-corrected midwall shortening ,89.2% 6.61 0.010 0.951 2.59 1.25–5.35
*Relative risk of strain compared to absence of strain, adjusted for age, gender, race, prevalent diabetes, systolic blood pressure, high density lipoprotein cholesterol and creatinine;
†relative risks calculated for presence of strain and compared with risk of normal geometry.
CHD 5 coronary heart disease; CI 5 confidence interval; LV 5 left ventricular; LVH 5 left ventricular hypertrophy.
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chamber dimension and wall thicknesses, and with an
increased relative wall thickness that nonetheless remained
within the normal range, such that the overall LV geometric
pattern reflected an eccentric hypertrophic response consis-
tent with increased LV volume load. The present study
extends these observations to a more heterogeneous popu-
lation of hypertensive patients, demonstrating that ECG
strain was associated with a greater prevalence of concentric
as opposed to eccentric LVH due to increased wall thickness
out of proportion to slightly increased LV chamber size after
controlling for other factors (Table 4).
Relationship of strain to LV performance. The relation
of ECG strain to measures of LV function has not been
previously examined in hypertensive patients. Devereux and
Reichek (3) and Roman et al. (11) found the prevalence of
reduced LV systolic function to be higher in patients with
the strain pattern. Moreover, Roman et al. (11) reported
lower fractional shortening by echocardiography and lower
ejection fraction on radionuclide angiography in patients
with strain. However, neither study examined measures of
LV contractility, nor did they adjust for possible confound-
ers by multivariate analyses. The present study extends these
observations to hypertensive patients with CHD demon-
strating lower myocardial contractility, as estimated by
stress-corrected midwall shortening (Table 4) and a more
than 2.5-fold greater prevalence of abnormally low stress-
corrected midwall shortening (Table 5), among CHD
patients with strain. However, strain was not associated
with depressed midwall shortening in patients without
evident CHD.
Mechanisms of abnormal repolarization. The present
study provides additional support for several possible mech-
anisms for the repolarization abnormalities of the strain
pattern in the absence of CHD. First, the association
between strain and a primarily concentric geometric pattern
of LVH, due to greater increases in LV wall thickness than
in chamber dimension, suggests a possible primary effect of
myocardial cell hypertrophy, consistent with the model
proposed by Thiry et al. (30). Second, ST depression and
T-wave inversion may reflect true subendocardial ischemia
in the absence of CHD attributable to increased LV mass
and wall thickness (32). This hypothesis is supported by the
association of strain with increased wall stress-mass-heart
rate product among patients without CHD, providing
evidence of a major demand-side predisposition to myocar-
dial ischemia. Indeed, although coronary artery size in-
creases with LV mass and is related to regional myocardial
mass (33), compensatory increases in coronary size, as
measured by lumen area to LV mass ratio, are frequently
inadequate to match the increased mass (33,34). The
finding that the ratio of coronary lumen area to regional LV
mass can partially normalize with regression of LVH after
aortic valve replacement for aortic stenosis (35) suggests that
repolarization abnormalities of strain may also diminish or
disappear with regression of hypertrophy after antihyper-
tensive therapy.
Implications. These findings have important clinical im-
plications. First, the increased morbidity and mortality
associated with anatomic LVH (24,25), and particularly
with concentric hypertrophy (25) and abnormal midwall LV
mechanics (29), provide new insights into the demonstrated
prognostic value of strain (8–10). The association of strain
with male gender and African-American race may in part
explain the higher event rates in these groups. These
findings and the subjective and qualitative nature of strain
criteria currently employed provide impetus to develop
quantitative, computerized ST segment and T-wave ampli-
tude measurements to identify LVH and stratify risk.
Further study is needed to determine whether hypertrophy
regression is associated with reversal or reduction of repo-
larization abnormalities of strain, and whether serial evalu-
ation of quantitative ST segment and T-wave measure-
ments will provide additional insight into this process.
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